Biden proposes subsidizing drug middlemen for insulin
World of DTC Marketing
MARCH 31, 2022
Research shows that the three-drug companies that dominate global insulin sales — Novo Nordisk, Eli Lilly, and Sanofi may not be entirely to blame for the soaring costs to people with diabetes. In 2014, researchers determined, 30% of insulin revenue went to middlemen. Los Angeles Times.
Let's personalize your content